CANY
PTVE

Caxton Associates (New York)’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Caxton Associates (New York)’s Portfolio PTVE Stock Details PTVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-16,634
Closed -$191K – 704
2024
Q3 		$191K Sell
16,634
-15,808
-49% -$181K 0.01% 491
2024
Q2 		$367K Buy
+32,442
New +$432K 0.01% 380

Other funds holding PTVE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caxton Associates (New York)'s PTVE Position: Q4 2024 in Review

Caxton Associates (New York) sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q4 2024, closing a stake of 16,634 shares — an estimated $191K sold.

Caxton Associates (New York) first reported a position in PTVE in Q2 2024 and held it in 2 quarters. The position peaked at $367K in Q2 2024. 161 funds tracked by Wall St. Rank hold PTVE as of Q4 2024.

  • Caxton Associates (New York) reported no remaining Pactiv Evergreen Inc. Common stock position as of Q4 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 16,634 Pactiv Evergreen Inc. Common stock shares in Q4 2024, an estimated $191K.
  • Caxton Associates (New York) first reported a position in Pactiv Evergreen Inc. Common stock in Q2 2024 and held it in 2 quarters.
  • Caxton Associates (New York)'s Pactiv Evergreen Inc. Common stock position peaked at $367K in Q2 2024.
  • 161 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.